A PHASE 2 TRIAL OF SALVAGE TREATMENT WITH GEMCITABINE AND S-1 COMBINATION IN HEAVILY PRETREATED PATIENTS WITH METASTATIC COLORECTAL CANCER

被引：0

作者：

Sym, S. J. ^{[1
]}

Hong, J. ^{[1
]}

Ahn, H. K. ^{[1
]}

Park, J. ^{[1
]}

Cho, E. K. ^{[1
]}

Lee, J. H. ^{[1
]}

Lee, W. ^{[2
]}

Baek, J. ^{[2
]}

Park, Y. H. ^{[2
]}

Shin, D. B. ^{[1
]}

机构：

[1] Gachon Univ, Gil Hosp, Dept Internal Med, Div Hematol & Oncol, Inchon, South Korea

[2] Gachon Univ, Gil Hosp, Dept Gen Surg, Inchon, South Korea

来源：

EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷

关键词：

D O I：

10.1016/S0959-8049(13)70005-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

AOSOP5

引用

页码：S3 / S3

页数：1

共 50 条

[1] A phase II trial of salvage treatment with gemcitabine and S-1 combination in heavily pretreated patients with metastatic colorectal cancer
Sym, Sun Jin
Hong, Junshik
Ahn, Hee Kyung
Park, Jinny
Cho, Eun Kyung
Lee, Jae Hoon
Lee, Won-Suk
Baek, Jeong-Heum
Park, Yeon Ho
Shin, Dong Bok
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
[2] A PHASE II TRIAL OF SALVAGE TREATMENT WITH GEMCITABINE AND S-1 COMBINATION IN HEAVILY PRETREATED PATIENTS WITH METASTATIC COLORECTAL CANCER
Sym, S. J.
Hong, J.
Jung, M.
Park, J.
Cho, E. K.
Lee, J. H.
Lee, W. -S.
Baek, J. -H.
Shin, D. B.
ANNALS OF ONCOLOGY, 2012, 23 : 151 - 152
[3] A phase II trial of salvage treatment with gemcitabine and S-1 combination in heavily pretreated patients with metastatic colorectal cancer
Sym, Sun Jin
Hong, Junshik
Ahn, Hee Kyung
Park, Jinny
Cho, Eun Kyung
Lee, Jae Hoon
Lee, Won-Suk
Baek, Jeong-Heum
Park, Yeon Ho
Shin, Dong Bok
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[4] A phase II trial of salvage treatment with gemcitabine and S-1 combination in heavily pretreated patients with metastatic colorectal cancer.
Sym, Sun Jin
Hong, Junshik
Jung, Minkyu
Park, Jinny
Cho, Eun Kyung
Lee, Jae Hoon
Lee, Won-Suk
Baek, Jeong-Heum
Shin, Dong Bok
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[5] Combination of trastuzumab and gemcitabine as salvage therapy in heavily pretreated patients with metastatic breast cancer
Bartsch, R.
Wenzel, C.
Pluschnig, U.
Altorjai, G.
Dubsky, P.
Scheurer, R.
Rottenfusser, A.
Gnant, M.
Zielinski, C. C.
Steger, G. G.
EJC SUPPLEMENTS, 2008, 6 (07): : 178 - 179
[6] Phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pretreated patients with metastatic colorectal cancer.
Yamaguchi, Kazuhisa
Taniguchi, Hiroya
Komori, Azusa
Narita, Yukiya
Uegaki, Shiori
Nitta, Sohei
Nomura, Motoo
Kadowaki, Shigenori
Takahari, Daisuke
Ura, Takashi
Andoh, Masashi
Muro, Kei
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
[7] A phase II trial of the combination gemcitabine plus vinorelbine in pretreated and heavily pretreated metastatic breast cancer patients, preliminary data.
Cacciari, N
Pinto, C
Giaquinta, S
Martoni, A
ANNALS OF ONCOLOGY, 2000, 11 : 37 - 37
[8] Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer
Sun Young Rha
Yong Hwa Moon
Hei Chul Jeung
Yong Tae Kim
Joo Hyuk Sohn
Woo Ick Yang
Chang Ok Suh
Gwi Eon Kim
Jae Kyung Roh
Hyun Cheol Chung
Breast Cancer Research and Treatment, 2005, 90 : 215 - 221
[9] Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer
Rha, SU
Moon, YH
Jeung, HC
Kim, YT
Sohn, JH
Yang, WI
Suh, CO
Kim, GE
Roh, JK
Chung, HC
BREAST CANCER RESEARCH AND TREATMENT, 2005, 90 (03) : 215 - 221
[10] Biweekly gemcitabine and capecitabine in heavily pretreated patients with metastatic colorectal cancer (mCRC)
Solis Hernandez, Maria Del Pilar
Jimenez, Paula
Faez Garcia, Laura
Alvarez Fernandez, Carlos
Perez Arnillas, Quionia
Rodriguez Rubi, David Jose
Lucrecia Ruiz, Ana
Sanchez Lorenzo, Luisa
Li Torres, Walter Antonio
Uriol, Esther
Dolores, Maria
Prieto, Menendez
Maria Vieitez de Prado, Jose
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)

← 1 2 3 4 5 →